Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LIM homeobox protein 4 (LHX4) is a transcription factor containing LIM domains, involved in regulating gene expression during embryonic development. It plays a critical role in the differentiation and development of the pituitary gland, retina, and certain parts of the nervous system. Mutations in LHX4 are associated with combined pituitary hormone deficiency, syndromic short stature, and other developmental defects of the pituitary and hindbrain. LHX4 is not currently a therapeutic target for drugs but is important for understanding disease mechanisms in endocrine and neural developmental disorders[1][3][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LIM homeobox protein 4 (LHX4).